New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 28, 2014
08:15 EDTNWBONorthwest's DCVax-Direct doesn't meet tumor response criteria, TheStreet says
None of 19 patients with advanced, metastatic cancers in an ongoing phase I trial have responded to treatment with Northwest Biotherapeutics' DCVax-Direct as defined by a standard known as RECIST, or Response Evaluation Criteria in Solid Tumors, which says partial response requires a 30% reduction in the size of the target lesion, according to TheStreet's Adam Feuerstein. Northwest's CEO Linda Powers said the greatest response seen so far after DCVax-Direct injections directly into a single tumor was a 28% reduction, according to Feuerstein. Reference Link
News For NWBO From The Last 14 Days
Check below for free stories on NWBO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 17, 2014
11:12 EDTNWBOOptions with decreasing implied volatility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use